Factors affecting visual acuity after one year of follow up after repeated intravitreal ranibizumab for macular degeneration
Aim: Providing intravitreal ranibizumab therapy for neovascular age related macular degeneration (nARMD) is a source of increasing strain for many UK eye departments. Whilst most units attempt to adhere to the product licence of following up patients at four weekly intervals; delays in follow up app...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-07-01
|
Series: | Saudi Journal of Ophthalmology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319453415000296 |